Sarepta Therapeutics, Inc. (SRPT)
Latest SRPT Insider Trades
About Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
- CAMBRIDGE, MA
- 835
- 1997
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 10 | 3,115,446 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
SRPT Insider Transactions (Form 4)
5046 Form 4 filings on record, the earliest from Nov 20, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Michael Severino - Officer | Grant or award | Common Stock | 756,104 |
Recent SRPT Form 8-K Filings
5SRPT Insider Trading - FAQ
What is the latest insider trade for SRPT?
Sarepta Therapeutics, Inc. (SRPT) had 9 insider filings in the last 90 days, with the most recent on 2026-07-30. The full record for SRPT runs to 46 Form 4 filings, the earliest from 2024-11-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying SRPT stock?
No insider purchases of SRPT were filed in the last 90 days.
How many insiders are selling SRPT stock?
No insider sales of SRPT were filed in the last 90 days. 4 sales are on record for this company.
Where can I see SRPT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks SRPT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow SRPT insider buys?
Create a free InsiderAlpha account and press Watch on this page to add SRPT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Michael Severino view on EDGAR
- - Kathryn Jean Boor view on EDGAR
- - Stephen Mayo view on EDGAR
- - Hans Lennart Rudolf Wigzell view on EDGAR
- - M. Kathleen Behrens view on EDGAR
- - Deirdre P. Connelly view on EDGAR
- - Claude Nicaise view on EDGAR
- - Michael Andrew Chambers view on EDGAR
- - Richard Barry view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where SRPT's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track SRPT insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.